Trials / Completed
CompletedNCT00082589
The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure
A Randomized, Double-Blind, Multi-Center,Study Evaluating the Effects of Eplerenone Versus Placebo on Ventricular Remodeling in Patient's With Left Ventricular Systolic Dysfunction (EF Less Than or Equal to 35%) and Mild to Moderate Heart Failure
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if eplerenone is effective in the treatment of mild to moderate heart failure
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eplerenone |
Timeline
- Start date
- 2004-04-01
- Completion
- 2006-03-01
- First posted
- 2004-05-14
- Last updated
- 2020-12-22
Locations
53 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00082589. Inclusion in this directory is not an endorsement.